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Background: Bizarre parosteal osteochondromatous proliferation (BPOP) is benign and usually occurs in the small
tubular bones of the hands and feet, but it is extremely rare in the oral and maxillofacial region.
Methods: The present study compares a case of BPOP occurring in the lingual area of the right mandibular body
with a representative case of osteochondroma occurring in the left mandibular condyle using immunohistochemical
methods.
Results: BPOP showed no continuity to the cortical bone of the mandible on X-ray and was histologically composed
of immature cartilage and bone tissues, whereas osteochondroma showed overgrowth of hypertrophic chondrocytes
accompanied by mature bone with endochondral ossification. Although BPOP showed no features of cellular atypia or
malignant transformation, it expressed more osteogenic proteins, including BMP-2, BMP-4, RUNX2, OC, AP, OPG,
RANKL, CTGF, and bFGF, than osteochondroma. Furthermore, the perichondral spindle cells and marrow osteoblasts/
fibroblasts of BPOP showed stronger immunoreaction of PCNA, p53, β-catenin, BCL2, pAKT, survivin, 14-3-3, CEA, EMA,
pan-K, and S-100 than the tumor cells of osteochondroma.
Conclusions: Therefore, it was presumed that similar to embryonal osteochondroid tissue, BPOP might be
activated by osteogenic and oncogenic signaling and that this increased signaling may explain the rapid growth
and high recurrence of BPOP.
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Bizarre parosteal osteochondromatous proliferation
(BPOP) is a rare, benign osteocartilaginous lesion which
was first described in 35 lesions from the small bones of
the hands and feet by Nora et al. in 1983 [1]. Many cases
involving various other sites, including the zygoma,
maxilla, and mandible, have been reported [2–5]. BPOP
usually shows key radiological features, including lack of
histological features characterized by three distinct com-
ponents with variable degrees of representation: (1)
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philic tinctorial quality; (2) cancellous bone undergoing
maturation; and (3) spindle cell stroma without cytologic
atypia [6–9]. BPOP, also known as Nora’s lesion, often
behaves like a malignant tumor, clinically and micro-
scopically [10]. Histological features of BPOP include
hypercellular spindle cells, a blue tinctorial quality in the
osteocartilaginous interfaces, and a scattering of binucle-
ated or bizarre enlarged chondrocytes [11].
Generally, it is presumed that BPOP arises from
periosteal tissues through a process of cartilaginous
metaplasia. BPOP can be easily confused, both clinic-
ally and microscopically, with other benign and malig-
nant lesions of the bone, including osteochondroma,
myositis ossificans, florid reactive periostitis, turretdistributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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coma [12, 13]. BPOP has been reported to have a
high rate of recurrence (about 50 %) but without me-
tastasis [9, 14]. Translocation between chromosomes
1 and 2, t(1;17)(q32;q21), and inversion of chromo-
some 7, inv(7)(q22q32), have been observed in BPOP
[15–17].
Osteochondroma is the most common tumor of the
skeletal bones, but it is relatively uncommon in the
jaws at the condyle or the tip of the coronoid process
[18]. This benign cartilage-capped tumor simulating
unilateral condylar hyperplasia is usually discovered
incidentally on radiographic examination or on palpa-
tion of a protruding mass in the affected area [19].
Malocclusion and progressive facial asymmetry are
common findings in most cases of condylar osteo-
chondroma [20]. Computed tomography and magnetic
resonance imaging depicted the central part of the
exophytic bone lesion as having continuity to the
underlying bone marrow, which is considered to be
the typical finding of osteochondroma compared to
BPOP [21, 22]. In addition, an inversion of chromo-
some 7 [inv (7)(q22q32)] has also been observed in
osteochondroma [23].Fig. 1 Radiographic views of this study. A Computed tomography of BPOP, a
body without cortical attachment (arrows). A1 Frontal plane. A2 Horizontal pl
head (arrows)The present study used immunohistochemical (IHC)
staining using different antisera to compare a case of
BPOP occurring at the lingual area of the right man-
dibular body to a representative case of osteochondroma
occurring in the left mandibular condyle.
Methods
A case of BPOP and osteochondroma
A 17-year-old female noticed a hard sublingual mass
3 months prior and experienced stiffness during yawn-
ing. The oral mucosa then became ulcerated, and a calci-
fied mass was exposed with whitish and partially bluish
color. On computed tomography, the mass was ovoid
and lobulated with irregular calcification and measured
about 30 × 20 mm on the lingual area of the right man-
dibular body. The calcified mass showed no continuity
with the cortical bone of the mandible on X-ray (Fig. 1A);
therefore, it was enucleated through simple intraoral dis-
section at Seoul National University Dental Hospital.
The removed specimen was submitted to the Department
of Oral Pathology, Gangneung-Wonju National University
Dental Hospital (GWNUDH) for analysis. It was com-
posed of cartilaginous and osseous tissues on gross obser-
vation. The cartilaginous tissue was approximated to then irregularly calcified mass located on the lingual side of the mandibular
ane. B Panoramic view of osteochondroma, enlarged left condylar
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tissue had grown toward the sublingual area (Fig. 2A).
The lesion was diagnosed as BPOP through pathological
examination (OS2014-25).Fig. 2 BPOP. A1 Sublingual ulceration with a whitish calcified mass. A2 Remo
composed of cartilaginous (1) and osseous (2) tissue. A4 Bizarre chondrocytes
(area 2 of A3). B1 and B3 show core cartilage covered with thick perichondra
from cartilaginous tissue, mimicking endochondral ossification. C–G IHC stainA 39-year-old female presented with severe malocclu-
sion and facial asymmetry, which had slowly progressed
for 4 years. She was referred to GWNUDH with a chief
complaint of slight pain on the left temporomandibularved mass showing partial bluish color (arrows). A3 BPOP specimen was
(arrows) in cartilaginous tissue. B HE stain. B1–B3 (area 1 of A3). B4, B5
l fibrous tissue. B4 and B5 show anastomosing trabecular bone centered
s with no background stain. C PCNA. D BMP-2. E BMP-4. F RUNX2. G OC
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was severely enlarged with cortico-medullary continuity
from adjacent bone structures on orthopantomogram
(Fig. 1B). The tumorous condyle was surgically removed
by high condylectomy and diagnosed as osteochondroma
through pathological examination (S2014-4).
Immunohistochemical study
The removed specimens of BPOP and osteochondroma
were separately fixed in 10 % neutral formalin, decalci-
fied with 5 % nitric acid, embedded with paraffin, and
sectioned to 4-μm thickness. The microsections were
routinely stained with hematoxylin and eosin (HE) and
immunohistochemical (IHC) staining using the following
antisera: proliferating cell nuclear antigen (PCNA; Santa
Cruz Biotech, USA), bone morphogenetic protein
(BMP)-2 (Santa Cruz Biotech), BMP-4 (Santa Cruz Bio-
tech), runt-related transcription factor 2 (RUNX2;
Abcam, Cambridge, UK), osteocalcin (OC; DAKO,
Denmark), alkaline phosphatase (AP; DAKO), osteopro-
tegerin (OPG; Santa Cruz Biotech), receptor activator of
nuclear factor-kappaB ligand (RANKL; Santa Cruz Bio-
tech), connective tissue growth factor (CTGF; Abcam),
basic fibroblast growth factor (bFGF; DAKO), p53 (Santa
Cruz Biotech), v-akt murine thymoma viral oncogene
homologue 1 (Santa Cruz Biotech), phosphorylated at
Thr 308 (pAKT), β-catenin (Santa Cruz Biotech), B cell
lymphoma 2 (BCL2; Santa Cruz Biotech), 14-3-3 (Santa
Cruz Biotech), survivin (Santa Cruz Biotech), carcinoem-
bryonic antigen (CEA; Santa Cruz Biotech), epithelial
membrane antigen (EMA; Abcam), pan-keratins (pan-K;
Santa Cruz Biotech), and S-100 (Santa Cruz Biotech,
USA). IHC staining was performed using the indirect
triple sandwich method [24, 25]. Our institutional review
board approved the examination of these biopsy speci-
mens by the Department of Oral Pathology, GWNUDH
(IRB 2015-07).
Results
On histological observation, the BPOP specimen dis-
closed inner cartilaginous tissue and outer osseous tissue
(Fig. 2A3). The cartilaginous tissue was immature and
contained many bizarre proliferating chondrocytes
(Fig. 2A4) with multifocally distributed perichondral fi-
brous tissue mainly composed of spindle cells (Fig. 2B1–
B3). The osseous tissue showed linearly elongated tra-
becular bones that stemmed from the cartilaginous tis-
sue (Fig. 2A3). The endochondral ossification was
almost abortive but extensively produced trabecular
bones (Fig. 2B4). There was no atypical cellular change;
however, the perichondral fibrous tissue was thickened
with proliferating spindle cells.
Osteochondroma, on the other hand, showed exophy-
tic growth of cartilaginous tissue, followed by trabecularbone ossification at the mandibular condyle. The con-
dylar cartilage almost entirely lacked perichondral fi-
brous tissue but contained a thick layer of aggregated
and proliferative hypertrophic chondrocytes (Fig. 5A).
Endochondral ossification was evident with features of
chondroid tissue embedded in ossifying bony tissue
(Fig. 5B).
IHC staining for osteogenetic protein expression in
the BPOP specimen was conspicuously positive for both
BMP-2 and BMP-4, which are known to indicate osteo-
genesis and chondrogenesis, respectively, while osteo-
chondroma was much more weakly positive for these
proteins. Particularly, the spindle cells of the perichon-
dral fibrous tissue and marrow osteoblasts and fibro-
blasts of BPOP were strongly positive for OC, AP, and
CTGF and consistently positive for OPG, RANKL, and
bFGF (Figs. 2D–G and 3), whereas the proliferating
chondrocytes and osteoblasts of osteochondroma
(Fig. 5A, B) were weakly positive for BMP-2, BMP-4,
OC, AP, OPG, CTGF, and bFGF and rarely positive for
RUNX2 and RANKL (Fig. 5D–L).
Regarding the proliferative activity observed by PCNA
immunoreaction, the BPOP specimen showed a con-
spicuous positive reaction in the spinous cells of the
perichondral fibrous tissue and in some osteoblasts/fi-
broblasts of the osseous tissue (Fig. 2C), while osteo-
chondroma was rarely positive (Fig. 5C).
On IHC staining of oncogenic protein expression, the
bizarre chondrocytes of BPOP were strongly positive for
β-catenin, BCL2, and pAKT and consistently positive for
p53 and survivin (Fig. 4B–F), while some tumor cells of
osteochondroma were positive for β-catenin and 14-3-3
and weakly positive for p53, pAKT, BCL2, and survivin
(Fig. 5M–R).
On the other hand, the biomarkers of chondrosar-
coma, such as CEA, EMA, pan-K, and S-100 [26–28],
showed a slight positive reaction in the spindle cells of
perichondral fibrous tissue (Fig. 4G–J) but an almost
negative reaction in the tumor cells of osteochondroma
(Fig. 4L–N).
Discussion
On histological observation of the present cases, osteo-
chondroma showed increased endochondral ossification
with overgrowth of hypertrophic chondrocytes, while
BPOP showed abortive endochondral ossification. The
immature cartilaginous tissue of BPOP abruptly pro-
duced the trabecular bones that were elongated linearly
in a radiating fashion from the core cartilage. While the
hypertrophic chondrocytes of osteochondroma produced
trabecular bones that were subsequently connected with
the original bone marrow, the cartilaginous tissue of
BPOP, probably derived from the parosteal mesenchyme,
produced trabecular bones in the external direction from
Fig. 3 BPOP. IHC stains with no background stain. A AP. B OPG. C RANKL. D CTGF. E bFGF. (1–3: cartilaginous tissue of Fig. 2A3. 4–5: osseous
tissue of Fig. 2A3)
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tween BPOP and the original bone. However, the tra-
becular bone growth of BPOP was more active and
extensive than that of osteochondroma, and BPOP had
multiple cartilaginous tissues which were immature and
diffusely scattered, while osteochondroma had a thick
cartilage cap on the condylar head. These findings dir-
ectly indicate that BPOP may have higher recurrence
rate than osteochondroma.
In the IHC stains, BPOP showed more intense expres-
sion of osteogenic proteins (BMP-2, BMP-4, RUNX2,
OC, AP, OPG, RANKL, CTGF, and bFGF) than the
ostoeochondroma. BMP-2 and BMP-4, which are
markers of osteogenesis and chondrogenesis, respect-
ively, were consistently positive in BPOP but only weakly
positive in osteochondroma. Furthermore, the bio-
markers of ossification (RUNX2, OC, AP, OPG, and
RANKL) and the biomarkers of mesenchymal growth
(bFGF and CTGF) were much stronger in BPOP than in
osteochondroma. It was thought that BPOP grew moreactively than osteochondroma by producing immature
cartilage and bone.
The higher expression of osteogenic proteins in BPOP
than in osteochondroma was coincident with increased
expression of PCNA in the perichondral spinous cells
and marrow osteogenic cells of BPOP. Osteochondroma
was rarely positive for PCNA. The present study also
performed IHC examination for different oncogenic pro-
teins (p53, β-catenin, BCL2, pAKT, and survivin) and
the biomarkers of chondrosarcoma (CEA, EMA, pan-K,
and S-100) in BPOP and osteochondroma. For the surgi-
cal approach for the osteochondroma, not like that for
BPOP, several factors, such as complete excision with
condylar reconstruction, mandibular contouring, and re-
construction of normal occlusion, must be considered.
Virtual surgical simulation for guidance of excision of the
mandibular condyle and combined correction of dentofa-
cial deformities can be recommended recently [29].
The oncogenic protein expression of perichondral spin-
dle cells and marrow osteoblasts/fibroblasts of BPOP was
Fig. 4 A–J BPOP. A HE stain, noted bizarre chondrocytes without cellular atypia. B–J IHC stains with no background stain. B p53. C β-catenin. D
BCL2. E pAKT. F Survivin. G CEA. H EMA. I pan-K. J S-100. K–N Osteochondroma. K HE stain noted the tumorous growth of chondrocytes. L CEA.
M EMA. N S-100.
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vivin, while osteochondroma was weakly positive for β-
catenin and 14-3-3 and rarely positive for p53, BCL2,
pAKT, and survivin. Furthermore, BPOP was consistentlypositive for CEA, EMA, pan-K, and S-100, while osteo-
chondroma was rarely positive for these proteins.
Immunohistochemically, BPOP showed the expression
of bFGF and vascular endothelial growth factor (VEGF),
Fig. 5 Osteochondroma. A, B HE stain noted hyperplastic chondrocytes undergoing abortive endochondral ossification. C–R IHC stains with
no background stain. C PCNA. D BMP-2. E BMP-4. F RUNX2. G OC. H AP. I OPG. J RANKL. K CTGF. L bFGF. M p53. N pAKT. O β-catenin. P BCL2.
Q 14-3-3. R Survivin.
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in the growth plate. Thus, BPOP is considered as a rep-
arative process which is occasionally confused with
other benign or malignant conditions [30]. It was pre-
sumed that BPOP was more strongly activated by the
oncogenic proteins (p53, β-catenin, BCL2, pAKT, and
survivin) than osteochondroma; BPOP might be af-
fected by oncogenic signaling of cellular proliferation
and survival. Eventually, BPOP produced CEA, EMA,
pan-K, and S-100, implying that BPOP might have
higher potential for malignant transformation than
osteochondroma. Since BPOP still showed no cellular
atypia and expressed only low levels of embryonic
chondrocyte proteins (CEA, EMA, pan-K, and S-100),
it was also presumed that the growth of BPOP was
primitive and immature, similar to the embryonal de-
velopment of cartilage and bone, i.e., Meckel’s cartilage
in mandible development, rather than to the progres-
sion of malignant transformation.Conclusions
The present study used IHC staining to compare a case
of BPOP occurring at the lingual area of the right man-
dibular body with a case of representative osteochon-
droma occurring at the left mandibular condyle.
Although the BPOP specimen showed no features of
cellular atypia or malignant transformation, it did ex-
press more osteogenic proteins (BMP-2, BMP-4,
RUNX2, OC, AP, OPG, RANKL CTGF, and bFGF) than
osteochondroma. Furthermore, the perichondral spin-
dle cells and marrow osteoblasts/fibroblasts of BPOP
showed stronger immunoreaction of PCNA, p53, β-
catenin, BCL2, pAKT, survivin, CEA, EMA, pan-K, and
S-100 than the tumor cells of osteochondroma. There-
fore, it was presumed that, similar to the embryonal
osteochondroid tissues, BPOP might be activated by
the osteogenic and oncogenic signalings and that this
increased growth signaling may explain the rapid
growth and high recurrence of BPOP.
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